Patent Yard Sign in
Canadian application, no grantCanada

Drug discovery using multiple membrane mimetic affinities

CA 2300863 A1 · Owner: Pidgeon, Charles · Inventors: Cai, Song J.; Liu, Hanlan; Pidgeon, Charles

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

The measurement of multiple membrane affinities of test compounds methods and , compositions useful for acquiring data characteristic of such affinities and , a method and system for using such data alone or in combination with other molecular descriptors for the prediction of biological activity are described. The numerical values characteristic of biologically relevant interaction of test compounds with membrane mimetic surfaces are compared with corresponding values of one or more control compounds having a known biological activity. Probable biological activity of a test compound is identified with those control compounds whose multiple membrane interaction values most closely …

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed August 21, 1998. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended August 21, 2018.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by August 21, 2020.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledAugust 21, 1998
GrantedNo grant recorded
Term endedAugust 21, 2018
Patent numberCA 2300863 A1
Classification (IPC)C12Q1/00 +2 more

Timeline

Timeline From CIPO dates

1999200120032005200720092011201320152017Application filedAug 21, 1998Term endedAug 21, 2018

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.